OBJECTIVE: Data regarding the value of prehospital measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) and troponin T as prognostic indicators of in-hospital mortality are limited. This prospective pilot study aimed to determine the value of a single combined measurement of NT-proBNP and troponin T for predicting in-hospital mortality in patients with acute ischaemic stroke in a prehospital emergency medicine centre. METHODS: Blood samples were collected in the prehospital setting and analysed for NT-proBNP and troponin T, using a portable device. Parameters previously associated with stroke severity (including prognostic scoring systems) were recorded and assessed as independent predictors of in-hospital mortality. RESULTS: In logistic regression analysis, elevated troponin T (odds ratio [OR] 1. 8 [95% CI 1.1, 8.4) and  elevated NT-proBNP (OR 5.80 [95% CI 1.3,  22.7] ) were significantly associated with poor outcome in patients with acute ischaemic stroke. Combined measurement of troponin T plus NT-proBNP was most predictive of survival in stroke patients (93% sensitivity, 96% specificity, 80% negative predictive value, 98% positive predictive value and 92% area under the receiver operating curve). CONCLUSIONS: NT-proBNP and troponin T levels, measured during the prehospital phase of care after acute ischaemic stroke, are strong predictors of in-hospital mortality.
Introduction
In patients presenting with acute stroke in the prehospital setting, early and accurate diagnosis -and recognition of disease severity and prognosis -often present significant clinical challenges. 1 -3 It has been suggested that brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) may be early markers
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These data were presented at the 31st International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 22 -25 March 2011 and published as an abstract in Grmec Š, Kit B, Hajdinjak E: Critical Care 2011; 15(suppl 1): 317. a Deceased. NT-proBNP and troponin T measurement after ischaemic stroke of acute stroke: each has been found to be useful for prediction of outcome and initial treatment in emergency departments. 4 -7 Elevated troponin levels are commonly observed following acute stroke and have been associated with electrocardiographic changes suggestive of myocardial ischaemia and increased risk of death. 8 -10 Combined testing of troponin T and NT-proBNP with standard clinical assessment has been suggested to be a superior prognostic tool in patients with heart failure than either test used alone. 11, 12 Given these data, it was hypothesized that a combination of NT-proBNP and troponin T testing may also have prognostic value in prehospital stroke patients. The present pilot study sought to determine the value of a single combined measurement of NT-proBNP plus troponin T for predicting in-hospital mortality in patients with acute ischaemic stroke, initially treated by the prehospital emergency medicine team in an out-ofhospital setting.
Patients and methods

STUDY POPULATION
Consecutive patients with acute stroke who were treated by emergency teams -including emergency physicians, registered nurses or medical technicians/drivers in an ambulance or at a prehospital emergency medicine centre -were enrolled in this prospective cohort study. The study was performed in a prehospital emergency setting at the Centre for Emergency Medicine Maribor, Slovenia, between June 2006 and May 2010. Following prehospital care, all patients were admitted to the University of Maribor Clinical Centre and monitored until discharge. All patients gave verbal informed consent to participate in the study and consent to publish the data. If patients were unconscious, verbal informed consent was obtained from relatives. Ethical approval for the study was obtained from the Ethical Review Board of the Ministry of Health of Slovenia.
Adult patients were included in the study if they had acute ischaemic stroke. This was defined as a sudden onset of neurological symptoms, with a diagnosis later confirmed in hospital by computed tomography (CT) or magnetic resonance imaging (MRI), and verified by neurologists and/or intensive care physicians at the University of Maribor Clinical Centre. Patients were excluded from study entry if they had any trauma, had a history of renal insufficiency or severe coronary ischaemia, or if they had any other causes of acute neurological symptomatology (e.g. haemorrhagic stroke, intracranial haemorrhage, tumours, inflammation).
STUDY MEASURES AND PROCEDURES
After enrolment, the following parameters were assessed in the prehospital emergency medicine centre: demographic characteristics; neurological signs and symptoms; medical history; measurement of systolic and diastolic blood pressure; oxygen saturation; electrocardiogram; blood glucose level; National Institutes of Health (NIH) stroke scale score (a scale of 0 -42, where 42 indicates most severe disease); 13 Los Angeles Motor Scale (LAMS) score (a scale of 0 -5, where 5 indicates most severe disease). 14 
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Evaluation II (APACHE II) score (a scale of 0 -71, where 71 indicates most severe disease), 15 TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification, routine laboratory analyses (including electrolytes and blood glucose levels) and CT or MRI data were obtained after hospitalization.
According to these parameters, identification of independent predictors of the final outcome of acute ischaemic stroke was made. During the initial evaluation (performed immediately on the patient's arrival at the prehospital emergency medicine centre, prior to the administration of any medication) a 4-ml blood sample was collected from each patient into a tube containing 63.84 IU of lithium heparin, for blinded measurement of NT-proBNP and troponin T. Levels of NT-proBNP and troponin T were measured using a portable Cardiac Reader device (Roche Cobas h232 system; Roche Diagnostics, Mannheim, Germany) and entered into an in-house protocol, designed for recording and collecting the data. Testing was completed within 15 min of collecting the blood sample. 2 Healthcare professionals who made the diagnosis of acute ischaemic stroke in the prehospital setting (prehospital emergency physicians), after hospitalization or at hospital discharge (neurologists and/or intensive care physicians) were blinded to the results of NT-proBNP and troponin T testing. In addition, the investigators performing NT-proBNP and troponin T testing were blinded to the final diagnosis.
Four measures were used to predict survival in stroke patients: troponin T alone; NT-proBNP alone; NIH stroke scale; troponin T plus NT-proBNP. Variables were tested for homogenity of variance with Levene's test for homogeneity, which is automatically reported in SPSS ® . Odds ratios (OR) and 95% confidence intervals were calculated for predicting mortality and adjusted using multiple logistic regression. In multiple logistic regression analysis, simultaneous entry of the variables into the regression equation was used. The area under the receiver operating curve (AUROC) was used to determine the prognostic value of the combination of troponin T and NT-proBNP compared with NT-proBNP alone, troponin T alone or the NIH stroke scale score alone for survival until hospital discharge of patients with stroke. Single areas were calculated and compared with univariate Z-score testing. AUROC analysis was performed using Analyse-it ® software (Analyse-it Software, Leeds, UK). A P-value < 0.05 was considered to be statistically significant. Cut-off values were determined for troponin T, NT-proBNP and NIH stroke scale score by data analysis for the best sensitivity-specificity balance in the receiver operating curves.
STATISTICAL ANALYSES
Results
During the study period, 310 consecutive patients with acute stroke were treated by emergency teams. Of these, 204 were excluded from the study (troponin T and NT-proBNP measures were unavailable or measurement was not blinded in 142 patients; 62 patients had haemorrhagic stroke). A total of 83 patients survived and 23 patients died in hospital following acute ischaemic stroke. The clinical and demographic characteristics of patients included in the study are presented in Table 1 . NT-proBNP and troponin T measurement after ischaemic stroke Compared with patients who died in hospital, survivors were significantly younger (P = 0.0057), had significantly lower levels of NT-proBNP (P < 0.0001) and fewer had elevated levels of troponin T (> 0.04 µg/l) (P = 0.0063). Overall, troponin T levels were elevated in 16 Causes of mortality were: nine strokerelated deaths (including three patients with elevated troponin T); six cases of pneumonia/infection (including two patients with elevated troponin T); four cardiac deaths (including one patient with elevated troponin T); four deaths from other causes (including two patients with elevated troponin T). The different causes of mortality were equally distributed between patients 14 3 (1 -3) 5 (4 -5) P < 0.0001 c APACHE II score 15 18.9 ± 3. For the identification of independent predictors of survival of acute ischaemic stroke, the 14 variables with P < 0.05 from univariate analysis were analysed by multivariate logistic regression. Twelve variables remained significant after analysis ( Table 2 ). Prognostic scorings (LAMS, NIH stroke scale and APACHE II) and NT-proBNP had the highest OR for predicting survival after acute ischaemic stroke. Elevated troponin T and NT-proBNP levels were significantly associated with poor short-term outcome (P = 0.020 and P < 0.001, respectively).
The sensitivity, specificity, positivepredictive value (PPV), negative-predictive value (NPV) and AUROC values for troponin T (cut-off point 0.20 µg/l), NIH stroke scale score (cut-off point a total of 20 points), NT-proBNP (cut-off point 700 pg/ml) and the combination of troponin T plus NT-proBNP are shown in Table 3 . NT-proBNP alone was statistically significantly more accurate in predicting survival following acute ischaemic stroke than troponin T alone or the NIH stroke scale score; this test was shown to have better sensitivity, specificity, NPV, PPV and AUROC (P < 0.01). The combination of troponin T and NT-proBNP was the most accurate measure for predicting survival in stroke patients; when compared with NT-proBNP alone, the combination measure was equally as sensitive, with a similar NPV, but had significantly better specificity, PPV and AUROC (P < 0.01). Compared with the NIH stroke scale score or troponin T alone, the troponin T plus NT-proBNP combination was 
Discussion
The present study demonstrated that positive troponin T and elevated NT-proBNP concentrations in the prehospital setting were significantly associated with a poor short-term outcome, for patients with acute ischaemic stroke. Prognostic scoring systems (LAMS, the NIH stroke scale and APACHE II) and NT-proBNP measurement had the highest OR for predicting survival after acute ischaemic stroke. This study also demonstrated that rapid bedside combination testing for troponin T together with NT-proBNP in the prehospital setting had the best AUROC: this was the most reliable method of those analysed for predicting survival in stroke patients.
In contrast to the current study, some research has shown that levels of troponin T, troponin I and NT-proBNP do not relate to clinical prognosis in acute ischaemic stroke. 16 In that study, the highest proportion of elevated parameters was found at days 2 and 3. 16 The present study was methodologically and conceptually different: its primary aim was to determine the value of a single combined measurement of NT-proBNP plus troponin T for predicting inhospital mortality in patients with acute ischaemic stroke in a prehospital emergency medicine centre. In addition, the connection between prehospital parameters and scoring systems (LAMS and NIH stroke) with hospital scoring (APACHE II) and outcome was established. The point-of-care method analysed in the current investigation was simple, fast and applicable in the field, and included only a single measurement of troponin T and NT-proBNP, performed immediately after arrival at the prehospital emergency medicine centre. This measurement may represent an efficient . Further research is planned to determine the prognostic value of point-ofcare combined NT-proBNP and troponin T measurements with a novel prehospital scoring system. Similar to the present study, research has shown that BNP levels in patients with acute ischaemic stroke are positively correlated with stroke severity, NIH stroke scale score and infarct volume. 17 That NT-proBNP could be an indicator of the general or vascular condition of patients with acute ischaemic stroke was demonstrated in a study that found elevated NT-proBNP levels predicted the risk of ischaemic stroke, in men from the general population. 6 It has also been suggested that NT-proBNP levels could be of clinical importance as a supplementary tool for the assessment of cardiovascular function in patients with stroke. 5 A systematic review of 15 studies found a similar relationship for elevated troponin after ischaemic stroke, since elevated troponin levels were associated with electrocardiographic changes, myocardial ischaemia and risk of death. 8 In patients presenting with ischaemic stroke but without overt ischaemic heart disease, elevation of troponin T -while rare -has been shown to be significantly associated with increased mortality. 9 Furthermore, elevation of troponin T appeared to be correlated with an elevated risk of death during the 2 years following stroke presentation. 9 The prognostic value of troponin T in ischaemic stroke was also observed in the current study. All patients with elevated troponin T had associated electrocardiographic changes (ST-segment depression), indicating the presence of coexisting ischaemic heart disease. Patients with acute ischaemic stroke should be offered adequate treatment with secondary prevention and, preferably, a follow-up (with a focus on cardiovascular monitoring), in addition to neurological monitoring. 10 -12 The prehospital verification of elevated levels of troponin T and NT-proBNP appears to be useful for identifying patients who are at increased risk of death and who would benefit from focused monitoring to prevent complications. 1 Elevated systolic and diastolic blood pressures were observed in patients who died following ischaemic stroke in the present study. It is possible that elevated arterial blood pressure contributed to the higher levels of NT-proBNP measured in these patients. Several studies have indentifed a correlation between mean arterial blood pressure and NT-proBNP levels, and have concluded that the simultaneous presence of hypertension and stroke results in a greater increase of NT-proBNP than the presence of either stroke or hypertension alone. 7, 18, 19 To our knowledge this is the first prospective study specifically designed to assess the utility of troponin T and NT-proBNP for the prognosis of acute ischaemic stroke in the prehospital setting. Prehospital emergency physicians offer the earliest management of acute stroke and, in this setting, it can be difficult to recognize the extent of disease based on clinical judgement alone. The application of combined NT-proBNP and troponin T measurements in prehospital emergency medicine settings could help to improve assessment of the severity and prognosis of acute stroke. In healthcare systems, such as that operating in Slovenia where there are medical doctors in prehospital settings, this methodology could improve clinical communication between prehospital and hospital teams. The importance of the transition of bedside point- 20, 21 It is possible that tests, such as combined troponin T plus NT-proBNP, could be performed by paramedics in the ambulance on the way to hospital. This is a simple way to apply point-of-care diagnostics in the prehospital setting and to obtain additional clinical information regarding the condition and prognosis of patients with acute ischaemic stroke. 22 The present study had some methodological limitations. First, this analysis only included patients with stroke diagnosed in the field, which limits the generalizability of the findings to all stroke patients (i.e. including those who are diagnosed in hospital). Secondly, data regarding early secondary prevention with statins and anticoagulation therapy -which may reduce early neurological deterioration and increase survival rates in patients presenting with acute stroke -were not collected. Thirdly, the number of outcome events observed in this study was relatively small. Fourthly, mortality was analysed during the hospital stay rather than at a defined timepoint in the days following stroke, although the latter may be more exact. Mortality analysed at a defined timepoint helps to diminish the impact of patients with very severe disease who are discharged directly to nursing homes soon after the stroke while they are still in a poor physical condition. Such patients often die within a few days following the stroke, but contributed to the group of survivors in the present study.
The applicability of the current study's approach to stroke patient management and the results of this pilot project must be confirmed in a multicentre prospective study, in the prehospital setting. 23 In conclusion, NT-proBNP and troponin T measurements during the prehospital phase of care following acute ischaemic stroke are predictors of in-hospital mortality and can improve the recognition of disease severity and prognosis. Both methods are simple, fast and can be used at the bedside or in the field to improve the out-of-hospital management of patients with acute ischaemic stroke.
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